For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

Plus, Brookfield drops deal for Spanish healthcare group Grifols and Sequoia Capital’s spun-off China unit hunts for global deals ...

JPMorgan Chase & Co.’s equity strategy team, led for years by Marko Kolanovic until his departure earlier in 2024, has turned ...

EUROPEAN equities fell as concerns mounted around the French government’s ability to push through its budget plan. Read more ...

This article summarizes current health news, covering topics like potential bone loss from thyroid medication, dementia risks from wildfire smoke, and updates on pharmaceutical pricing policies. It ...

Canadian investment fund Brookfield said Wednesday it has dropped its bid for Spanish pharmaceutical firm Grifols following ...

Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over ...

Grifols' American depositary receipts slumped following a report that Brookfield Asset Management plans to abandon its acquisition of the Spanish pharmaceuticals company. The stock was down 18% at ...

Brookfield abandons takeover of Grifols over valuation issues, affecting shares. Future talks uncertain as IBEX 35 dips.

Grifols (GRFS) stock dropped as Brookfield Asset Management (BAM) is reportedly withdrawing its offer to take the plasma ...

Among French lenders, Societe Generale and BNP Paribas fell around 2% each. The risk premium investors demand to hold French debt rose to its highest level since 2012, a sign of investor angst over ...

The Grifols family won’t support a new bid by a third-party to take its namesake drug-maker private amid indications that ...